Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Clinical trial NCT00957372 · COMPLETED

Trial details

NCT number: NCT00957372
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial Epilepsy

Start date: 2004-12-01
Primary completion: 2008-06-01
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.